© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
January 18, 2021
B.1.1.7, or otherwise known as VOC 202012/01, may lead to a large increase in the number of COVID-19 cases in the United States and may become the dominant strain of the virus in the coming months.
January 14, 2021
For patients with COVID-19, mitochondria are one of the first lines of defense in fighting the virus.
January 13, 2021
Approximately one-third of children with COVID-19 are asymptomatic, according to a study conducted by researchers at the University of Alberta.
January 12, 2021
Moderna, Inc has also announced temporary authorization of its COVID-19 vaccine in Switzerland.
The study authors said their main hypothesis for the higher prevalence of olfactory dysfunction in mild COVID-19 cases was based on differences in the immune response to the infection.
January 06, 2021
Despite fringe conspiracy theories that circulated online, COVID-19 carries a greater risk of health problems than the flu.
January 05, 2021
Reports indicate a mortality rate of up to 28% among solid organ transplant patients hospitalized with coronavirus disease 2019.
Pharmacy Times® interviewed Alan Green, the US head of sales, infectious disease at AstraZeneca, on the Flu+Force campaign and the resources it provides to help pharmacists develop alternative flu vaccination sites.
An individual’s response to the flu virus is largely shaped by preexisting immunity.
December 23, 2020
Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.